Korro shared more preclinical data for KRRO-110 at the American Thoracic Society 2024 International Conference.

KRRO-110 showed sustained editing efficiency of approximately 60% and increased total alpha-1 antitrypsin (AAT) protein levels to greater than 60uM at week 13 in an in vivo genetic Alpha-1…

Read More: https://www.globenewswire.com/news-release/2024/05/20/2885071/0/en/Korro-Presents-Additional-Preclinical-Data-for-KRRO-110-at-the-American-Thoracic-Society-2024-International-Conference.html